文献速递乳房整形与再造显微修复重建

自体乳房再造中肋骨切除与肋骨保留的结果分析

Rib Resection vs. Rib Preservation in Autologous Breast Reconstruction: An Outcome Analysis of 234 Patients.
PubMed 文献 · Plast Reconstr Surg · 2026-02-12

该回顾性研究分析2018至2023年单中心234例自体乳房再造,比较肋骨切除163例与肋骨保留71例。肋骨保留组缺血时间较长,但受区血管蒂更长、动脉直径更大、术后阿片类药物使用更短、疼痛更轻、失血量及引流量更少、随访干预更少(包括脂肪移植)。作者认为技术可行时肋骨保留应作为首选。

要点

  • 肋骨保留组缺血时间较长,但血管蒂更长、动脉直径更大。
  • 肋骨保留组术后阿片类药物使用更短、疼痛更轻、失血及引流量更少。
  • 肋骨保留组随访干预更少,脂肪移植比例更低。

核心结论

  • 肋骨保留法在减少术后并发症和改善美学效果、减少二次干预方面显著优于肋骨切除法。
  • 技术可行时,肋骨保留应被视为自体乳房再造的首选方法。

研究设计与样本

  • 单中心回顾性研究,分析2018至2023年234例自体乳房再造。
  • 肋骨切除组163例,肋骨保留组71例。
  • 收集术中数据、术后止痛药使用及至少1年随访干预情况。

主要发现

  • 缺血时间肋骨切除组为45:00分钟(IQR 37:44-60:00),肋骨保留组为50:59分钟(IQR 43:59-71:00),p=0.006。
  • 血管蒂长度肋骨保留组为11 cm(IQR 10-12),肋骨切除组为10 cm(IQR 9.5-11),p=0.074。
  • 动脉直径肋骨保留组更大,p=0.084。
  • 术后阿片类药物治疗时间肋骨切除组为3天(IQR 2-4.25),肋骨保留组为2.5天(IQR 1.63-3),p=0.019。
  • 术后第一天疼痛评分肋骨切除组更高,p=0.049;失血量p=0.033,引流量p<0.001。

关键数值与推荐

  • 肋骨切除组缺血时间显著更短(p=0.006)。
  • 肋骨保留组术后阿片类药物治疗时间显著更短(p=0.019)。
  • 肋骨切除组术后第一天疼痛显著更高(p=0.049)。
  • 肋骨切除组失血量(p=0.033)和引流量(p<0.001)显著更多。
  • 肋骨切除组随访干预次数显著更多(p=0.001),脂肪移植比例更高(35% vs. 20.3%,p=0.029)。

临床怎么用

  • 在自体乳房再造中,若技术上可行,优先考虑肋骨保留技术以减少术后并发症和二次干预。
  • 肋骨切除虽可缩短缺血时间,但术后疼痛、阿片类药物使用及引流量增加,需权衡利弊。

局限性

  • 单中心回顾性研究设计。
  • 样本量有限(234例),两组样本量不均(163 vs. 71)。
  • 随访时间至少1年,可能不足以评估长期结局。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: In autologous breast reconstruction, the internal mammary artery is the preferred recipient vessel. Although rib-resecting is usually performed, the rib-preserving technique has gained increasing attention in recent years without being scientifically evaluated. METHODS: In our retrospective study, we analyzed 234 autologous breast reconstructions performed between 2018 and 2023 at a single hospital, comparing 163 patients who underwent rib resection with 71 patients who received the rib-preserving technique. Intraoperative data, postoperative pain medication usage, and follow-up interventions over a minimum of one year were screened. RESULTS: Ischemia time was significantly shorter in the rib-resecting group (45:00 min, IQR 37:44-60:00) compared with the rib-sparing group (50:59 min, IQR 43:59-71:00; p = 0.006). However, the rib-sparing group had longer pedicle lengths (11, IQR 10-12 vs. 10, IQR 9.5-11 cm; p = 0.074) and larger arterial diameters (p = 0.084). Postoperatively, rib-resecting patients required longer opioid treatment (3, IQR 2-4.25 vs. 2.5, IQR 1.63-3 days; p = 0.019), reported greater pain on the first postoperative day (p = 0.049), and exhibited more blood loss and drainage volume (p = 0.033, p = <0.001). Follow-up procedures were more frequent in the rib-resecting group (1, IQR 1-3) than in the rib-sparing group (1, IQR 0-1; p = 0.001), including lipofilling (35% vs. 20.3%, p = 0.029). CONCLUSION: The rib-sparing approach shows significant advantages over rib-resection, particularly in terms of reduced postoperative morbidity and more aesthetically pleasing result with fewer secondary interventions. When technically feasible, it should be considered the preferred method in autologous breast reconstruction.Clinical Question/Level of Evidence.

来源:Plast Reconstr Surg,查看原文。版权归原作者所有。

引用

  1. Aitzetmüller-Klietz ML, Jakob HHL, Hirsch T, et al. Rib Resection vs. Rib Preservation in Autologous Breast Reconstruction: An Outcome Analysis of 234 Patients. Plast Reconstr Surg. 2026. PMID: 41677348. doi:10.1097/PRS.0000000000012922

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。